Abstract
Various human diseases are known to occur as a result of gene-environment interactions. Amongst such diseases, neurodegenerative Parkinson’s disease (PD) is a complex disorder in which genetics and exposure to toxins constitute the main determinants in the onset of the disease. Many studies have reported on a link between pesticide exposure and increased risk of PD, however the role of different classes of pesticides vis-à-vis Parkinsonism has not been well elucidated. We carried out the present study to explore the role of six groups of pesticides viz botanicals, herbicides, fungicides, organophosphates, carbamates and pyrethroids on PD and and associated neurotoxic effects. These pesticides were studied using transgenic Caenorhabditis elegans model expressing human alpha synuclein protein tagged with yellow fluorescent protein [NL5901; (Punc-54::alphasynuclein::YFP+unc-119)] in the body wall muscle. Amongst all the classes of pesticides examined, botanical rotenone showed severe effects on PD pathogenesis. It significantly increased alpha synuclein aggregation and oxidative stress. Furthermore, it reduced mitochondrial and lipid content in the worms. Pesticides from other classes were observed to exert marginal effects as compared to rotenone thus suggesting that there is a class or structure specific effect of environmental chemicals vis-à-vis Parkinsonism. Hence it may be deduced that all classes of toxicants do not induce similar effects on neurodegeneration and associated events.
Keywords: Parkinson disease, α-synuclein, pesticides, Caenorhabditis elegans.
CNS & Neurological Disorders - Drug Targets
Title:Environmental Toxicants as Extrinsic Epigenetic Factors for Parkinsonism: Studies Employing Transgenic C. elegans Model
Volume: 11 Issue: 8
Author(s): Pooja Jadiya and Aamir Nazir
Affiliation:
Keywords: Parkinson disease, α-synuclein, pesticides, Caenorhabditis elegans.
Abstract: Various human diseases are known to occur as a result of gene-environment interactions. Amongst such diseases, neurodegenerative Parkinson’s disease (PD) is a complex disorder in which genetics and exposure to toxins constitute the main determinants in the onset of the disease. Many studies have reported on a link between pesticide exposure and increased risk of PD, however the role of different classes of pesticides vis-à-vis Parkinsonism has not been well elucidated. We carried out the present study to explore the role of six groups of pesticides viz botanicals, herbicides, fungicides, organophosphates, carbamates and pyrethroids on PD and and associated neurotoxic effects. These pesticides were studied using transgenic Caenorhabditis elegans model expressing human alpha synuclein protein tagged with yellow fluorescent protein [NL5901; (Punc-54::alphasynuclein::YFP+unc-119)] in the body wall muscle. Amongst all the classes of pesticides examined, botanical rotenone showed severe effects on PD pathogenesis. It significantly increased alpha synuclein aggregation and oxidative stress. Furthermore, it reduced mitochondrial and lipid content in the worms. Pesticides from other classes were observed to exert marginal effects as compared to rotenone thus suggesting that there is a class or structure specific effect of environmental chemicals vis-à-vis Parkinsonism. Hence it may be deduced that all classes of toxicants do not induce similar effects on neurodegeneration and associated events.
Export Options
About this article
Cite this article as:
Jadiya Pooja and Nazir Aamir, Environmental Toxicants as Extrinsic Epigenetic Factors for Parkinsonism: Studies Employing Transgenic C. elegans Model, CNS & Neurological Disorders - Drug Targets 2012; 11 (8) . https://dx.doi.org/10.2174/1871527311211080006
DOI https://dx.doi.org/10.2174/1871527311211080006 |
Print ISSN 1871-5273 |
Publisher Name Bentham Science Publisher |
Online ISSN 1996-3181 |
Call for Papers in Thematic Issues
Diagnosis and treatment of central nervous system infectious diseases
Infectious diseases of the central nervous system (CNS) can be divided into bacterial, tuberculous, viral, fungal, parasitic infections, etc. Early etiological treatment is often the most crucial means to reduce the mortality rate of patients with central nervous system infections, reduce complications and sequelae, and improve prognosis. The initial clinical ...read more
Techniques of Drug Repurposing: Delivering a new life to Herbs & Drugs
Of late, with the adaptation of innovative approaches and integration of advancements made towards medical sciences as well as the availability of a wide range of tools; several therapeutic challenges are being translated into viable clinical solutions, with a high degree of efficacy, safety, and selectivity. With a better understanding ...read more
Trends and perspectives in the rational management of CNS disorders
Central nervous system (CNS) diseases enforce a significant global health burden, driving ongoing efforts to improve our understanding and effectiveness of therapy. This issue investigates current advances in the discipline, focusing on the understanding as well as therapeutic handling of various CNS diseases. The issue covers a variety of diseases, ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Buprenorphine-Mediated Transition from Opioid Agonist to Antagonist Treatment: State of the Art and New Perspectives
Current Drug Abuse Reviews Hemothorax
Current Respiratory Medicine Reviews Current Options and Future Possibilities for the Treatment of Dyskinesia and Motor Fluctuations in Parkinson's Disease
CNS & Neurological Disorders - Drug Targets Acute Myocarditis in Children: An Overview of Treatment and Recent Patents
Recent Patents on Inflammation & Allergy Drug Discovery Drugs in Newborn Resuscitation: The More We Learn the Least We Use
Current Medicinal Chemistry The Evolution of Pharmacological Treatment for Parkinsons Disease
Recent Patents on CNS Drug Discovery (Discontinued) Stress in Gastrointestinal Tract and Stable Gastric Pentadecapeptide BPC 157. Finally, do we have a Solution?
Current Pharmaceutical Design Therapeutic Potential of Targeting the Endocannabinoids: Implications for the Treatment of Obesity, Metabolic Syndrome, Drug Abuse and Smoking Cessation
Current Medicinal Chemistry Alogliptin; A Review of a New Dipeptidyl Peptidase-4 (DPP-4) Inhibitor for the Treatment of Type 2 Diabetes Mellitus
Cardiovascular & Hematological Disorders-Drug Targets Enantioresolution of Chiral Derivatives of Xanthones on Different Types of Liquid Chromatography Stationary Phases: A Comparative Study
Current Chromatography Difference in Blood Pressure Measurements Between Arms: Methodological and Clinical Implications
Current Pharmaceutical Design Non-IgE Mediated Food Allergy
Inflammation & Allergy - Drug Targets (Discontinued) Analgesic and Antineuropathic Drugs Acting Through Central Cholinergic Mechanisms
Recent Patents on CNS Drug Discovery (Discontinued) The Role of NPY and Ghrelin in Anorexia Nervosa
Current Pharmaceutical Design Isoniazid: Metabolic Aspects and Toxicological Correlates
Current Drug Metabolism Angiotensin II Roles in Human Vascular Tone Control
Clinical Immunology, Endocrine & Metabolic Drugs (Discontinued) The Effects of Newer Beta-Adrenoceptor Antagonists on Vascular Function in Cardiovascular Disease
Current Vascular Pharmacology The Role of Corticosteroids in Sepsis and Acute Respiratory Distress Syndrome
Current Respiratory Medicine Reviews The Renin-Angiotensin System in the Mammalian Central Nervous System
Current Protein & Peptide Science Differential Regulation of microRNAs in Patients with Ischemic Stroke
Current Neurovascular Research